PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 214 filers reported holding PDL BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $15,965,000 | -6.5% | 3,173,883 | +19.6% | 0.07% | 0.0% |
| Q2 2015 | $17,066,000 | +20.7% | 2,654,120 | +32.1% | 0.07% | +23.7% |
| Q1 2015 | $14,140,000 | +12.9% | 2,009,880 | +23.8% | 0.06% | +11.3% |
| Q4 2014 | $12,522,000 | +2.4% | 1,624,130 | -0.8% | 0.05% | -1.9% |
| Q3 2014 | $12,231,000 | -33.0% | 1,637,390 | -13.2% | 0.05% | -30.8% |
| Q2 2014 | $18,256,000 | +6.8% | 1,885,900 | -8.3% | 0.08% | +4.0% |
| Q1 2014 | $17,090,000 | +8.3% | 2,056,500 | +10.0% | 0.08% | +8.7% |
| Q4 2013 | $15,783,000 | -3.8% | 1,870,000 | -9.2% | 0.07% | -8.0% |
| Q3 2013 | $16,411,000 | +1.8% | 2,059,100 | -1.4% | 0.08% | 0.0% |
| Q2 2013 | $16,126,000 | – | 2,088,800 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KESTREL INVESTMENT MANAGEMENT CORP | 1,634,000 | $4,804,000 | 1.81% |
| SMH CAPITAL ADVISORS INC | 80,722 | $237,000 | 0.37% |
| Matarin Capital Management, LLC | 1,126,641 | $3,312,325,000 | 0.25% |
| Hillsdale Investment Management Inc. | 337,800 | $993,000 | 0.14% |
| Zebra Capital Management LLC | 115,431 | $339,000 | 0.12% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,789,702 | $14,082,000 | 0.08% |
| Fortis Advisors, LLC | 45,602 | $134,000 | 0.07% |
| Municipal Employees' Retirement System of Michigan | 500,080 | $1,470,000 | 0.07% |
| RBF Capital, LLC | 173,090 | $508,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 392,276 | $1,153,000 | 0.06% |